$5.46
-0.03(-0.55%)
Mkt Cap $58M
$3.28
$9.10
52-Week Range
At a Glance
AI-generatedVerrica Pharmaceuticals Inc.
Revenue breakdown: License And Collaboration Revenue Milestones (38.5%), Product (30%), License And Collaboration Revenue (29.2%).
8-K
Verrica Pharmaceuticals Inc. filed an 8-K on March 11, 2026, disclosing results of operations under Item 2.02, with Exhibit 99.1 Press Release attached. The information under Item 2.02 and Exhibit 99.1 is not deemed 'filed' for purposes of Section 18 of the Exchange Act.$58M
Market Cap
$36M
Revenue
-$18M
Net Income
Employees71
Fundamentals
How The Business Makes Money
Revenue by Segment
License And Collaboration Revenue Milestones38.5%($56M)
Product30%($44M)
License And Collaboration Revenue29.2%($43M)
License And Collaboration Revenue Commercial Supply And Development2.3%($3M)
Activity
Analyst View
Company Profile
CIK0001660334
ISINUS92511W2070
CUSIP92511W207
Phone484 453 3300
Address44 West Gay Street, West Chester, PA, 19380, US
SEC EDGAR